Clinical and economic impact of non-adherence in COPD: A systematic review

Respiratory Medicine

Volumn 108, Issue 1, 2014, Pages 103-113

  Van Boven, Job F M ^a   Chavannes, Niels H ^b   Van Der Molen, Thys ^c,d   Rutten Van Mölken, Maureen P M H ^e   Postma, Maarten J ^a   Vegter, Stefan ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Adherence; COPD; Economics; Outcomes

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; IPRATROPIUM BROMIDE; ORCIPRENALINE; SALBUTAMOL; TIOTROPIUM BROMIDE; XANTHINE DERIVATIVE;

ABSENTEEISM; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISABILITY; DISEASE EXACERBATION; DRUG COST; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MORTALITY; NEBULIZER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRODUCTIVITY; PROFILE OF MOOD STATES; QUALITY OF LIFE; QUESTIONNAIRE; RECENT LIFE CHANGES QUESTIONNAIRE; SICKNESS IMPACT PROFILE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADHERENCE; COPD; ECONOMICS; OUTCOMES;

ALGORITHMS; EFFICIENCY; EVIDENCE-BASED MEDICINE; HUMANS; LENGTH OF STAY; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 84893697230     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.08.044     Document Type: Article

References (37)

1. P. Calverley, R. Pauwels, J. Vestbo, P. Jones, N. Pride, and A. Gulsvik et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial Lancet 361 2003 449 456
2. P.M. Calverley, J.A. Anderson, B. Celli, G.T. Ferguson, C. Jenkins, and P.W. Jones et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
3. J.A. Cramer, A. Roy, A. Burrell, C.J. Fairchild, M.J. Fuldeore, and D.A. Ollendorf et al. Medication compliance and persistence: terminology and definitions Value Health 11 2008 44 47
4. J.A. Cramer, C. Bradley-Kennedy, and A. Scalera Treatment persistence and compliance with medications for chronic obstructive pulmonary disease Can Respir J 14 2007 25 29
5. J. Bourbeau, and S.J. Bartlett Patient adherence in COPD Thorax 63 2008 831 838
6. R.D. Restrepo, M.T. Alvarez, L.D. Wittnebel, H. Sorenson, R. Wettstein, and D.L. Vines et al. Medication adherence issues in patients treated for COPD Int J Chron Obstruct Pulmon Dis 3 2008 371 384
7. M.S. Charles, C.M. Blanchette, H. Silver, D. Lavallee, A.A. Dalal, and D. Mapel Adherence to controller therapy for chronic obstructive pulmonary disease: a review Curr Med Res Opin 26 2010 2421 2429
8. P.M. Ho, J.S. Rumsfeld, F.A. Masoudi, D.L. McClure, M.E. Plomondon, and J.F. Steiner et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus Arch Intern Med 166 2006 1836 1841
9. R. Balkrishnan, R. Rajagopalan, F.T. Camacho, S.A. Huston, F.T. Murray, and R.T. Anderson Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study Clin Ther 25 2003 2958 2971
10. J.A. Rizzo, T.A. Abbott 3rd, and S. Pashko Labour productivity effects of prescribed medicines for chronically ill workers Health Econ 5 1996 249 265
11. M.J. Makela, V. Backer, M. Hedegaard, and K. Larsson Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD Respir Med 107 2013 1481 1490
12. S.D. Ramsey Suboptimal medical therapy in COPD: exploring the causes and consequences Chest 117 2000 33S 37S
13. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264, 269, W64
14. M. Egger, P. Juni, C. Bartlett, F. Holenstein, and J. Sterne How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study Health Technol Assess 7 2003 1 76
15. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, and J.P. Vandenbroucke et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies J Clin Epidemiol 61 2008 344 349
16. G.S. Carls, M.C. Roebuck, T.A. Brennan, J.A. Slezak, O.S. Matlin, and T.B. Gibson Impact of medication adherence on absenteeism and short-term disability for five chronic diseases J Occup Environ Med 54 2012 792 805
17. L. Simoni-Wastila, Y.J. Wei, J. Qian, I.H. Zuckerman, B. Stuart, and T. Shaffer et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population Am J Geriatr Pharmacother 10 2012 201 210
18. E. Dompeling, P.M. Van Grunsven, C.P. Van Schayck, H. Folgering, J. Molema, and C. Van Weel Treatment with inhaled steroids in asthma and chronic bronchitis: long-term compliance and inhaler technique Fam Pract 9 1992 161 166
19. E.L. Toy, N.U. Beaulieu, J.M. McHale, T.R. Welland, C.A. Plauschinat, and A. Swensen et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs Respir Med 105 2011 435 441
20. R. Halpern, C.L. Baker, J. Su, K.B. Woodruff, R. Paulose-Ram, and V. Porter et al. Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease Patient Prefer Adherence 5 2011 375 388
21. R.J. Butler, T.K. Davis, W.G. Johnson, and H.H. Gardner Effects of nonadherence with prescription drugs among older adults Am J Manag Care 17 2011 153 160
22. J. Vestbo, J.A. Anderson, P.M. Calverley, B. Celli, G.T. Ferguson, and C. Jenkins et al. Adherence to inhaled therapy, mortality and hospital admission in COPD Thorax 64 2009 939 943
23. J. Turner, E. Wright, L. Mendella, and N. Anthonisen Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent positive pressure breathing Chest 108 1995 394 400
24. K. Matuszewski, P. Velayudhan, N. Flint, and P. Pierpaoli Noncompliance with drug therapy for chronic obstructive pulmonary disease: a risk factor for hospitalization? Value Health 2 1999 446 451
25. M. Takemura, K. Mitsui, R. Itotani, M. Ishitoko, S. Suzuki, and M. Matsumoto et al. Relationships between repeated instruction on inhalation therapy, medication adherence, and health status in chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 6 2011 97 104
26. Z.M. Corden, C.M. Bosley, P.J. Rees, and G.M. Cochrane Home nebulized therapy for patients with COPD: patient compliance with treatment and its relation to quality of life Chest 112 1997 1278 1282
27. P.W. Jones, F.H. Quirk, C.M. Baveystock, and P. Littlejohns A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am Rev Respir Dis 145 1992 1321 1327
28. T. Agh, A. Inotai, and A. Meszaros Factors associated with medication adherence in patients with chronic obstructive pulmonary disease Respiration 82 2011 328 334
29. K. Herland, J.P. Akselsen, O.H. Skjonsberg, and L. Bjermer How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease? Respir Med 99 2005 11 19
30. J.F. Van Boven, S. Vegter, T. Van Der Molen, and M.J. Postma COPD in the working age population: the economic impact on both patients and government COPD 2013 July 11 10.3109/15412555.2013.813446 [Epub ahead of print]
31. A.S. Melani, M. Bonavia, V. Cilenti, C. Cinti, M. Lodi, and P. Martucci et al. Inhaler mishandling remains common in real life and is associated with reduced disease control Respir Med 105 2011 930 938
32. M.R. DiMatteo Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research Med Care 42 2004 200 209
33. F. Penning-van Beest, M. van Herk-Sukel, R. Gale, J.W. Lammers, and R. Herings Three-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysis Respir Med 105 2011 259 265
34. T. van der Molen, B.W. Willemse, S. Schokker, N.H. ten Hacken, D.S. Postma, and E.F. Juniper Development, validity and responsiveness of the Clinical COPD Questionnaire Health Qual Life Outcomes 1 2003 13
35. P.W. Jones, G. Harding, P. Berry, I. Wiklund, W.H. Chen, and N. Kline Leidy Development and first validation of the COPD Assessment Test Eur Respir J 34 2009 648 654
36. S.C. Lareau, and B.P. Yawn Improving adherence with inhaler therapy in COPD Int J Chron Obstruct Pulmon Dis 5 2010 401 406
37. J. Demonceau, T. Ruppar, P. Kristanto, D.A. Hughes, E. Fargher, and P. Kardas et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis Drugs 73 2013 545 562